BioCentury
ARTICLE | Company News

Pfizer to develop ONC's reovirus for animal use

November 20, 2000 8:00 AM UTC

PFE obtained worldwide development and commercialization rights from ONC to use in animals of reovirus, which infects and kills cancer cells with an activated Ras pathway. ONC will provide support to ...